Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$502,100
-9.47%
Shares
Shares Volume: 10,000 Shares
Average Share Price: $50.21
INSIDER
Yale Catriona
Chief Development Officer (Officer)
reported on Feb 21 2025
traded on Feb 18 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 95,648 |
| PURCHASES/SALES 1Y | 0 / 15 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $657,434.44 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 1 / 3 |
| PURCHASES/SALES 1Y | 1 / 55 |
| P/S VALUE RATIO | 0.239 |
| AVERAGE SALE VALUE | $730,234.53 |
| COMPANY PREVIOUS TRADES |